Northern Ireland-based technology company ubloquity has announced a new collaboration with pharmaceutical logistics specialist Trans-Bridge Freight Services Ltd to digitise and strengthen temperature-controlled shipments between Great Britain and the island of Ireland, deploying its ubiNex platform across Trans-Bridge's cold-chain operations on one of Europe's most regulated freight corridors.

According to Sync NI, the partnership will unify previously fragmented logistics data, including temperature monitoring, GPS tracking, consignment authentication and documentation, into a single secure, real-time system. The platform creates a tamper-evident digital record of each shipment, giving authorised stakeholders from shippers to regulators access to a single trusted source of information, enabling faster border processes and reduced administrative burden.

Kieran Kelly, CEO of ubloquity, said: "By bringing together authentication, real-time tracking, and compliance into a single platform, we're enabling Trans-Bridge to move critical pharmaceutical products with greater certainty, transparency and efficiency, while maintaining the highest standards of safety and regulatory compliance."

Brian Anderton, Director at Trans-Bridge Freight Services Ltd, said: "The ubiNex platform supports our operation in all these responsibilities by combining hi-tech security, temperature visibility, GPS traceability and document control in one centralised dashboard. Visibility to all trusted parties in our network gives immediate access to trusted information, reducing delays and assuring the highest compliance."

Pharmaceutical distribution across the Irish Sea has grown increasingly complex, with Windsor Framework requirements placing greater demands on documentation, auditability and compliance for operators moving regulated products between Great Britain and Ireland.

The deployment builds on ubloquity's wider Secure Freight initiative, which has already supported more than 1,700 cross-border journeys and facilitated the movement of over £180m of goods across its network.

For Trans-Bridge, the implementation addresses five core pillars the company identifies as central to its pharmaceutical and healthcare client obligations: regulatory compliance, product efficacy, patient safety, ESG and security.

Discover the full details of ubloquity's Trans-Bridge contract and the ubiNex platform deployment in the full story.